These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1561967)

  • 1. Patient interpretation of label instructions.
    Holt GA; Dorcheus L; Hall EL; Beck D; Ellis E; Hough J
    Am Pharm; 1992 Mar; NS32(3):58-62. PubMed ID: 1561967
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristics of container labeling in a sample of commonly prescribed children's oral medications.
    Wallace LS; Keenum AJ; DeVoe JE
    Res Social Adm Pharm; 2010 Dec; 6(4):272-9. PubMed ID: 21111385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA gets advice on Modernization Act compliance.
    Marwick C
    JAMA; 1998 Oct; 280(14):1214-5. PubMed ID: 9786361
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety warnings and first aid instructions on consumer and pharmaceutical products in Nigeria: has there been an improvement?
    Nonyelum SC; Nkem N; Ifeyinwa CN; Orisakwe OE
    J Pak Med Assoc; 2010 Oct; 60(10):801-4. PubMed ID: 21381605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriate use of drugs by elderly people.
    Wade B; Bowling A
    J Adv Nurs; 1986 Jan; 11(1):47-55. PubMed ID: 3632985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription for error.
    Wootton J
    Nurs Times; 1975 Jun; 71(23):884-6. PubMed ID: 1134965
    [No Abstract]   [Full Text] [Related]  

  • 7. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 8. Prescription for trouble: common drugs, hidden dangers. Tens of people are at risk.
    Consum Rep; 2006 Jan; 71(1):34-9. PubMed ID: 16491527
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter to the editor concerning Ufer et al.: Eur J Clin Pharmacol 58:779-783 (2003).
    Gleiter CH; Bücheler R; Schwab M
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):491; author response 493-4. PubMed ID: 12898085
    [No Abstract]   [Full Text] [Related]  

  • 10. The case for preemption of prescription drug failure-to-warn claims.
    Kim CH
    Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacogenomic information in the Warning section of drug labels: A comparison between labels in the United States and those in five other countries/regions.
    Imatoh T; Sai K; Saito Y
    J Clin Pharm Ther; 2018 Aug; 43(4):493-499. PubMed ID: 29682780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric information in drug product labeling.
    Sachs AN; Avant D; Lee CS; Rodriguez W; Murphy MD
    JAMA; 2012 May; 307(18):1914-5. PubMed ID: 22570457
    [No Abstract]   [Full Text] [Related]  

  • 13. Developing compliance instructions for drug labeling.
    Levy G; Zamacona MK; Jusko WJ
    Clin Pharmacol Ther; 2000 Dec; 68(6):586-91. PubMed ID: 11180017
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient package inserts: the proper prescription?
    Rowe HM
    Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988
    [No Abstract]   [Full Text] [Related]  

  • 15. Individualized, comprehensive drug education.
    Martin M
    Fam Community Health; 1982 Aug; 5(2):22-33. PubMed ID: 10317217
    [No Abstract]   [Full Text] [Related]  

  • 16. Milliliter-only instructions could reduce parents' dosing errors.
    Wallis L
    Am J Nurs; 2014 Oct; 114(10):16. PubMed ID: 25251114
    [No Abstract]   [Full Text] [Related]  

  • 17. The learned intermediary doctrine: past, present and future.
    Alsobrook HB
    Leg Med; 1994; ():269-80. PubMed ID: 7830482
    [No Abstract]   [Full Text] [Related]  

  • 18. The "Lists": What Do They Mean?
    Voliva J
    Int J Pharm Compd; 2016; 20(6):477-479. PubMed ID: 28339386
    [No Abstract]   [Full Text] [Related]  

  • 19. Off-label or off-limits?
    Ritchey ML
    J Urol; 2013 Jul; 190(1):8-9. PubMed ID: 23608037
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of PRO label claims granted by the FDA as compared to the EMA (2006-2010).
    DeMuro C; Clark M; Doward L; Evans E; Mordin M; Gnanasakthy A
    Value Health; 2013 Dec; 16(8):1150-5. PubMed ID: 24326168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.